Back to
Independent Review Committee
Gavi has established an Independent Review Committee for the review of new proposals

Gavi has established an Independent Review Committee for the review of new proposals
Since its inception, the structure and composition of the Gavi IRC have been considered effective due to key characteristics:
The IRC is directly accountable to the Gavi Board and communicates its recommendations to the Gavi Board. The Gavi Board makes the ultimate decision on whether to approve the funding of new country grants. The Gavi Board also has the responsibility for communicating its decision to countries, via the Gavi Secretariat.
Keeping in mind the realistic planning timelines, countries should target a submission deadline that meets their implementation timelines.
The mandate of the new proposals IRC is to review each application for all types of new support, to enable a more holistic view of the broad portfolio of support Gavi provides to countries, rather than looking at each new application in isolation from the others, and to make recommendations to the Gavi Board.
This review should consider the information available to countries within current guidelines and application forms and ensure that any new proposal contributes to achieving:
It also ensures that each new application for support complies with the eligibility criteria, established according to the Gavi guidelines for new proposals of support.
Round opening (on the portal) |
2023 Deadline for submission |
2023 IRC meeting |
---|---|---|
~2mths prior |
17 January |
13–24 March |
~2mths prior |
18 April |
19–30 June |
~2mths prior |
18 July |
19–29 September |
~2mths prior |
3 October |
27 Nov – 8 Dec |
Members of the Independent Review Committee consist of specialists from a broad range of expertise.
IRC members generally serve a term of three years. This term may be renewed for another period of up to 3 years. Upon reaching the second term limit IRC members will not be eligible to serve on the IRC for at least 1 year. During their term IRC members may be called upon to serve on the IRC for review of country plans or requests for extensions for which he or she has specific relevant skills.
The increasing complexity of new proposals and the subsequent grant monitoring requires an IRC with a broad range of expertise in areas such as:
The IRC should also consist of technical experts knowledgeable on the developing country context and relevant issues, including in a variety of fields related to immunisation and health systems, and who have practical experience working in or with developing country governments, civil society, and other partners in those contexts. In addition, the IRC should be geographically diverse, with a male and female representation consistent with Gavi’s Gender Policy and Guidelines on the Gavi Board Gender Balance.
Each IRC member is asked to sign a confidentiality and conflict of interest statement and will not come from Vaccine Alliance partner agencies, and have not taken part in technical assistance to or pre-review processes of country applications.
|
Name |
Areas of expertise |
---|---|---|
1 | Zenaw Adam | HSS, innovative strategies, data quality, project management, human capacity building, MCH, NVS/epidemiology, measles |
2 | Borja Cuervo Alonso | Access to primary healthcare services in low resource settings; HSS; disaster risk reduction; emergency relief; support to refugees and IDPs |
3 | Alvaro Alonso Garbayo | Health systems development, immunization, NGOs, fragile countries, cholera outbreaks, humanitarian health |
4 | Beatriz Ayala-Öström | HSS, supply chain management and resilience, system investments for vaccine preventable pandemics, project management, implementation and evaluations |
5 | Andrew Azman | Infectious disease epidemiology, cholera, hepatitis E, water and sanitation related diseases, infectious disease dynamics, vaccine study design, seroepidemiology |
6 | Saidou Pathé Barry | HSS, national health strategies, policy dialogue in the health sector, M&E, primary health care |
7 | Sabine Beckmann | Public health, community-based primary health care, routine and mass vaccination campaigns and supply chain management, M&E, technical assistance |
8 | Blaise Bikandou | HSS, policy development, vaccine preventable diseases, epidemiology, health programme management and administration |
9 | Francois Boilloit | Disease control, health system development and reform, health financing, development assistance for health |
10 | Diego Buriot | Public health interventions, communicable diseases, fragile and crisis settings |
11 | Brent Burkholder | Epidemiology, vaccine programmes and disease control, outbreak investigations |
12 | Lisa Cairns | Immunisation policy, epidemiology, M&R control, national immunisation programme reviews |
13 | Aleksandra Caric | Immunisation, vaccine safety and regulation, programme management and administration |
14 | Valerie Chambard | iSC Expert in vaccine management, EVM assessment and cold chain inventory and gap analysis |
15 | Rochika Chaudhry | Primary Health Care, outbreaks, epidemics and emergency response, malaria, health finance, health policy and planning, M&E |
16 | Dah Cheikh | Organization and management of vaccination programmes, HSS, vaccine campaigns, trainings |
17 | Sadia Chowdhury | Reproductive Health, HSS, child health services, programme delivery, M&E of health programmes |
18 | John Crump | Infectious diseases, epidemiology, outbreak responses, typhoid |
19 | Henrique D’Alva | Cold chain, EPI logistics |
20 | Teklay Desta | Managing immunization program, Vaccine Preventable Disease surveillance and outbreak investigation, New vaccine introduction and data management |
21 | Ousmane Dia | HSS, project/program management, capacity building, supply chain management of health commodities, vaccine and cold chain management |
22 | Mohamed Dramé | HSS, health policy dialogue, process & impact evaluation, health financing, human resource for health, community health, immunization systems |
23 | Rene Dubbeldam | National health policies, essential medicines strategies, child health programmes, community health, epidemiology |
24 | Linda O'Neal Eckert | Infectious diseases, vaccine preventable disease policy and program development, epidemiology |
25 | Ogijo Arome Emmanuel | Compliance, financial management, risk management, operations |
26 | Emmanuelle Espié | Infectious diseases epidemiology, outbreak investigation and response, epidemic preparedness, vaccinology, vaccine effectiveness and safety, capacities building in LMIC |
27 | Tene-Alima Essoh | Vaccine clinical development and advocacy for market access,HSS, new vaccine introduction, strategies addressing vaccine hesitancies and pharmacovigilance. |
28 | Peter Fonkwo | Health programme design and management, routine &mass campaigns vaccination, HSS, EPI M&E |
29 | Kate Gallagher | Infectious disease epidemiology and vaccine delivery |
30 | Eleonora Genovese | Health specialist, HSS expert in conflict countries, hard-to-reach communities, epidemics |
31 | Djordie Gikic | HSS, proposal development, immunisation systems evaluation, service delivery, health policies |
32 | Melita Gordon | Gastroenterology, disease surveillance, typhoid, vaccine trials |
33 | John Grundy | Health policy, campaign delivery, HSS, programme evaluation |
34 | Eusèbe Hounsokou | Emergency programmes, refugee health/conflict settings, ebola, equity |
35 | Natasha Howard | Health policy, social epidemiology, immunisation service delivery, fragile setting, strong academic background |
36 | Yilchini Ishaku | Cold chain and vaccine logistics management, routine immunization, new vaccine introduction, EVM, HSS |
37 | Hector Izurieta | Immunisation campaign management, public health, measles control, epidemiology, policy making |
38 | Philippe Jaillard | Health system strengthening, health and immunization supply chain management, new vaccine introduction, training and educational engineering |
39 | Barbara Johnson | Public health laboratory assessments, diagnostic laboratory training, development differential diagnostic testing algorithms, improving diagnostic assays |
40 | Jean Rostand Kamga | Financial & budget analysis, management and governance, audits, financial investigations |
41 | Toagoe Karzon | Project funding, financial reporting and budget control, conducting audits |
42 | Henry Stanley Katamba | Infectious and non-communicable diseases epidemiology incl. malaria, M&E of health programmes; strategic partnerships, health research and advisory |
43 | Tcha Landry Kaucley | Cold Chain, vaccine logistics, EPI monitoring & evaluation, public health management |
44 | Wassim Khrouf | Financial & budget analysis, audits, project assessment |
45 | Joses Kirigia | HSS efficiency and productivity analysis; costing and economic evaluation of public health programmes; analysis of economic burden of disease |
46 | Per Kronslev | Pharmaceutical supply chains serving public health |
47 | Stefano Lazzari | Outbreak, epidemic and emergency response, HSS, monitoring and evaluation, grant management |
48 | Dominique Legros | Epidemiology of infectious diseases (incl. cholera), surveillance, vaccinology, operational research, management of outbreaks and of complex emergencies |
49 | Rose Leke | Immunology of parasitic infections, particularly malaria. Global Health, HSS, training of the next generation of scientists |
50 | Dafrossa Lyimo | Immunisation campaign management, public health, health systems management, health policies, disease control |
51 | Tippi Mak | Vaccinology and scientific reviews for immunisation policy, safety and regulation. Late-phase vaccine development, epidemiologic research and primary care |
52 | Viviana Mangiaterra | Child health, epidemiology, HSS, immunisation programmes |
53 | Osman Mansoor | Immunisation programmes, epidemiology & monitoring, measles control, cold chain & logistics |
54 | Florian Marks | Public health, vaccinology and policy making, outbreak responses, campaign evaluations |
55 | Jean-Pierre Matwanga | Budgeting, financial management, procurement, portfolio/project management, grant management |
56 | Anne McArthur-Lloyd | NVS introduction; immunization system strengthening and assessment; training and community engagement |
57 | Mark Miller | Epidemiology, vaccine research, public health, outbreak investigations, disease control |
58 | Abdul-Aziz Mohammed | Immunization Supply Chain with expertise in vaccine Management; cold chain planning and supply chain strengthening; vaccine management and cold chain assessment |
59 | Nkengafac Villyen Motaze | Vaccinology, infectious disease epidemiology, clinical epidemiology, systematic reviews, evidence-based practice and pharmaco-epidemiology |
60 | Sandra Mounier-Jack | Immunisation programmes, health systems strengthening, HPV vaccine, measles elimination, health policy and health financing |
61 | Kondwani Msampha | Financial & budget analysis, HSS, global health and integrated service delivery |
62 | Pierre Corneille Namahoro | Cold-chain logistics, health and pharmaceutical supply chain, HSS, project design and management, M&E and financial management |
63 | Alex Nartey | Health financing, public financial management, project management, funds and grants management |
64 | Sophie Newland | Health technology evaluation and introduction; cold chain equipment inventory and maintenance data management; and healthcare waste management systems |
65 | Benjamin Nkowane | Vaccine preventable disease programmes, implementation of mass vaccination campaigns, technical support for field operations in security risk areas, epidemiology and reproductive/sexual health |
66 | Mathieu Noirhomme | Public health, HSS, health policy dialogue, health financing, design thinking & service design, universal health coverage |
67 | Cornelius Oepen | HSS, urban health, health security, mass vaccination/campaigns, evaluation of research programmes |
68 | Abiola Ayodeji Ojumu | Child health and immunisation programs,HSS, strategic planning and health policy development, supply chain management,NVS introduction planning and execution |
69 | Jean Marc Olive | Immunisation programmes, emergency strategies & disaster relief, measles elimination |
70 | Walter Orenstein | Assessment of vaccine effectiveness, vaccine hesitancy&enhance uptake, polio eradication and measles elimination |
71 | Edward Ouko | Auditing and public financial management, governance, monitoring and evaluation |
72 | Bolanle Oyeledun | Health systems strengthening, MNCH, immunisation, adolescent reproductive health & HPV, programme assessments and evaluations |
73 | Femi Oyewole | Role of laboratories in disease control at various levels of health care delivery. Designing, implementing and evaluating activities in the area of vaccine-preventable diseases |
74 | Jean-Paul Paolo | Supply chain management, cold chain logistics, vaccines management, EVMA, e-LMIS, waste management, supply chain costing |
75 | Michael Park | Programme management and evaluation, primary care, health systems and public health |
76 | Elisabeth Paul | Health systems and policies, health financing, universal health coverage, performance-based financing, aid effectiveness |
77 | Obed Philip | Procurement and supply chain management and governance, vaccines management and system design, public health logistics management |
78 | Giorgi Pkhakadze | Public health, HSS, project/program design, planning, M&E, control of communicable and non-communicable diseases, change management |
79 | Robert Pond | HSS, NVS, validation of immunization coverage estimates, assessment/reinforcement of countries’ approaches to data quality assurance |
80 | Susan Rackstraw | Health strategy, design, policy and program implementation in fragile and emergency settings, planning, budgeting and financial management, establishment and review of policy and governance mechanisms, HSS |
81 | Bastiaan Remmelzwaal | Cold chain and vaccine management, EVM assessments, Facility and Equipment Maintenance and Inventories and pharmaceutical supply chain management |
82 | Chandrakant Ruparelia | HSS, disease outbreak response, innovations to improve access to healthcare, and integration of health services, implementation of national guidelines, quality improvement |
83 | Helen Saxenian | Health financing, public financial management, costing, economic evaluation, public-private engagement in immunization, fiscal policies for health |
84 | Soleine Scotney | Health and immunisation systems strengthening, PHC (including infectious diseases, MCH), vaccine market dynamics, supply chain management, health programme implementation, policy development, budgeting, M&E |
85 | Jim Setzer | Health information systems, HSS, disease surveillance, programme and policy planning, M&E, strategic planning |
86 | Mario Stassen | Immunization supply chain logistics (iSCL) and Cold chain logistics, quality assurance incl. vaccines, health systems strengthening and management, bridging the gap between strategy and operations |
87 | Simon (Sam) Sternin | Global health generalist, HSS, disaster management, coverage and equity, CSOs |
88 | Gavin Surgey | Health economics and financing; HSS; health technology assessment |
89 | Ousmane Amadou Sy | Financial and grant management; technical assistance; public health policy; program design/planning and implementation; health and community systems strengthening |
90 | Patricia Taylor | Routine immunization, new vaccine introduction, MNBCH, community and urban health, health information systems, capacity development |
91 | Joanne Thomson | Public health, gender equality, disability and social inclusion, development of humanitarian good practice standards, programme design and evaluation |
92 | Abdelmajid Tibouti | Financial & budget analysis, health economics, health financing strategies, monitoring and evaluation |
93 | Oyewale Tomori | Laboratory systems and support for infectious disease prevention, diagnosis and control |
94 | Vivien Tsu | Epidemiology, new public health interventions, women's reproductive health, HPV, JE |
95 | Beena Varghese | Evaluation of health interventions including cost and cost-effectiveness analysis; design of research methods for health systems analyses; and health financing |
96 | Margaret Watkins | Immunisation campaign management, epidemiology, public health interventions, outbreaks, evaluations |
97 | Erika Wichro | Pandemic preparedness planning and outbreak response, HSS, re-emerging infectious diseases, risk assessment, ebola, polio, measles, malaria, public health, strategic crisis management, epidemiology |
98 | Charles Shey Wiysonge | Vaccinology, HSS, vaccine hesitancy, epidemiology, systematic reviews, programme management |
99 | Aregai Woldegebriel | Epidemiology, SIA, MNCH, outbreaks, monitoring and evaluation |